Vir Biotechnology, Inc. Business Finance Contracts & Agreements
14 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (2)
- Warrant Agreements (1)
- Stock Purchase Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022 (Filed With SEC on February 28, 2022)
- Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021 (Filed With SEC on May 6, 2021)
- Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020 (Filed With SEC on July 6, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
- Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019 (Filed With SEC on March 26, 2020)
- Description of Capital Stock (Filed With SEC on March 26, 2020)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 30, 2019)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on September 30, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 30, 2019)
- Securities Purchase Agreement between the Registrant, Humabs BioMed SA, the shareholders of Humabs set forth therein, the option-holders of Humabs set forth therein and Fortis... (Filed With SEC on September 3, 2019)
- Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017 (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
- Amended and Restated Warrant, issued to Takeda Ventures, Inc (Filed With SEC on September 3, 2019)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 29, 2017 (Filed With SEC on September 3, 2019)
